SARS-CoV-2: a storm is raging

Pedersen, Savannah F., Ho, Ya-Chi·2020·Journal of Clinical Investigation

Cited by (1,000)

Items 401–500 of 1,000

  1. IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6
    Evgeny Lvovich Nasonov · 2020 · Rheumatology Science and Practice
  2. COVID‐19, internists and resilience: the north‐south Italy outbreak
    Agostino Di Ciaula, Vincenzo Ostilio Palmieri, Giovanni Migliore, Piero Portincasa, the IMC‐19 Group · 2020 · European Journal of Clinical Investigation
  3. Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment
    Syed Shadab Raza, Mohsin Ali Khan · 2020 · Cytotherapy
  4. Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients
    María Martínez‐Urbistondo, Alberto Mora Vargas, Esther Expósito-Palomo, Raquel Castejón, María Jesús Citores, Silvia Rosado, Carmen de Mendoza, Isolina Baños, Ana Fernández‐Cruz, Lidia Daimiel et al. · 2020 · Mediators of Inflammation
  5. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient
    Roberta Rizzo, Luca Maria Neri, Carolina Simioni, Daria Bortolotti, Savino Occhionorelli, Giorgio Zauli, Paola Secchiero, Chiara Marina Semprini, Ilaria Laface, Juana María Sanz et al. · 2021 · Clinical Microbiology and Infection
  6. Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review
    Jyoti Choudhary, Shrivardhan Dheeman, Vipin Kumar Sharma, Prashant Katiyar, Santosh Kumar Karn, Manoj Kumar Sarangi, Ankit Kumar Chauhan, Gaurav Verma, Nitin Baliyan · 2021 · Biological Procedures Online
  7. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
    Annalisa Noce, Maria Albanese, Giulia Marrone, Manuela Di Lauro, Anna Pietroboni Zaitseva, Daniela Palazzetti, Cristina Guerriero, Agostino Paolino, Giuseppa Pizzenti, Francesca Di Daniele et al. · 2021 · Pharmaceuticals
  8. Health impact assessment of air pollutants during the COVID-19 pandemic in a Brazilian metropolis
    Marcos Lorran Paranhos Leão, Júlia Oliveira Penteado, Sabrina Morales Ulguim, Romulo Reginato Gabriel, Marina dos Santos, Aline Neutzling Brum, Linjie Zhang, Flávio Manoel Rodrigues da Silva Júnior · 2021 · Environmental Science and Pollution Research
  9. Cancer Occurrence as the Upcoming Complications of COVID-19
    Ilnaz Rahimmanesh, Laleh Shariati, Nasim Dana, Yasaman Esmaeili, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard · 2022 · Frontiers in Molecular Biosciences
  10. Why such excess of mortality for COVID-19 in Spain?
    Vincent Soriano, Pablo Barreiro · 2020 · Therapeutic Advances in Infectious Disease
  11. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us
    Vijay Kumar · 2020 · International Reviews of Immunology
  12. Immune Correlates of COVID-19 Control
    B. Poonia, S. Kottilil · 2020 · Frontiers in Immunology
  13. N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects
    Cristiane J. Nunes-Santos, Hye Sun Kuehn, Sergio D. Rosenzweig · 2020 · Journal of Clinical Immunology
  14. Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
    A. Banerjee, Upasana Ganguly, S. Saha, S. Chakrabarti, R. Saini, R. Rawal, L. Saso, Sasanka Chakrabarti · 2021 · Expert Review of Anti-Infective Therapy
  15. Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases
    Mahmoud Elashiry, Ranya Elsayed, Mohamed Mohamed Elashiry, Mohammad H. Rashid, Roxan Ara, Ali S. Arbab, Ahmed El‐Awady, Mark W. Hamrick, Yutao Liu, Wenbo Zhi et al. · 2021 · Frontiers in Immunology
  16. Frailty Pathogenesis, Assessment, and Management in Older Adults With COVID-19
    Quan She, Bo Chen, Wen Liu, Min Li, Weihong Zhao, Jianqing Wu · 2021 · Frontiers in Medicine
  17. CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients
    Lucille Adam, Pierre Rosenbaum, Paul Quentric, Christophe Parizot, Olivia Bonduelle, Noëlline Guillou, Aurélien Corneau, Karim Dorgham, Makoto Miyara, Charles Edouard Luyt et al. · 2021 · JCI Insight
  18. Changes of Host Immunity Mediated by IFN-γ+ CD8+ T Cells in Children with Adenovirus Pneumonia in Different Severity of Illness
    Ruilin Zheng, Yinghua Li, Danyang Chen, Jingyao Su, Ning Han, Haitian Chen, Zhihui Ning, Misi Xiao, Mingqi Zhao, Bing Zhu · 2021 · Viruses
  19. Reactive arthritis occurring after COVID-19 infection: a narrative review
    Maroua SLOUMA, Maissa Abbes, Takoua Mehmli, Rim Dhahri, L. Métoui, Imen Gharsallah, Bassem Louzir · 2022 · Infection
  20. Polypropylene Modified with Ag-Based Semiconductors as a Potential Material against SARS-CoV-2 and Other Pathogens
    Marcelo Assis, Lara Kelly Ribeiro, Mariana Ottaiano Gonçalves, Lucas H. Staffa, Robert da Silva Paiva, Laís R. Lima, Dyovani Coelho, Lauana Fogaça de Almeida, Leonardo Nazário de Moraes, Ieda L. V. Rosa et al. · 2022 · ACS Applied Polymer Materials
  21. Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review
    Paweł Kozłowski, Aleksandra Leszczyńska, Olga Ciepiela · 2024 · American Journal of Medicine Open
  22. Candidate Psychotropics against SARS – CoV – 2: A Narrative Review
    Mohsen Khosravi · 2021 · Pharmacopsychiatry
  23. A Double-Edged Sword—Cardiovascular Concerns of Potential Anti-COVID-19 Drugs
    Wen‐Liang Yu, Han Siong Toh, Chia‐Te Liao, Wei‐Ting Chang · 2020 · Cardiovascular Drugs and Therapy
  24. Systemic Complications of COVID-19
    Obaid Ashraf, Meilin Young, Khalid J. Malik, Tariq J. Cheema · 2020 · Critical Care Nursing Quarterly
  25. Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?
    Antonio Simone Laganà, Vittorio Unfer, Simone Garzon, Mariano Bizzarri · 2020 · Medical Hypotheses
  26. Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients
    Prisca Mutinelli-Szymanski, Iulia Hude, Emilie Merle, Yannis Lombardi, Pascal Seris, Medhi Abtahi, Latifa Azeroual, C. Bourgain, Gaël Ensergueix, Ioannis Katerinis et al. · 2020 · Clinical Kidney Journal
  27. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
    Esmaeil Mortaz, Ali Bassir, Neda Dalil Roofchayee, Neda K. Dezfuli, Hamidreza Jamaati, Payam Tabarsi, Afshin Moniri, Mitra Sadat Rezaei, Payam Mehrian, Mohammad Varahram et al. · 2021 · International Immunopharmacology
  28. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review
    Shukur Wasman Smail, Muhammad Saeed, Twana Alkasalias, Zhikal Omar Khudhur, Delan Ameen Younus, Mustafa Fahmi Rajab, Wayel Habib Abdulahad, Hafiz Iftikhar Hussain, Kamal Niaz, Muhammad Safdar · 2021 · Food and Chemical Toxicology
  29. BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome
    Venkatesh Pooladanda, Sowjanya Thatikonda, Sai Priya Muvvala, Geetanjali Devabattula, Chandraiah Godugu · 2021 · International Journal of Pharmaceutics
  30. The role of SARC-F scale in predicting progression risk of COVID-19 in elderly patients: a prospective cohort study in Wuhan
    Yao Ma, Min He, Lisha Hou, Xu Shen, Zhixin Huang, Na Zhao, Yan Ming Kang, Jirong Yue, Chenkai Wu · 2021 · BMC Geriatrics
  31. Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19
    Li Wang, Yuhe Wang, Wei Yang, Xue He, Shilin Xu, Xiaoli Liu, Yongjun He, Qunying Y. Hu, Dongya Yuan, Tianbo Jin · 2021 · Journal of Medical Microbiology
  32. Neutrophil extracellular traps: new aspects
    Н. В. Воробьева · 2020 · Bulletin of Moscow University, Series 16. Biology (Moscow University)
  33. COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy
    Mansoor Khaledi, Fatemeh Sameni, Sheida Yahyazade, Maedeh Radandish, Parviz Owlia, Nader Bagheri, Hamed Afkhami, Mohamad Mahjoor, Zahra Esmaelpour, Maryam Kohansal et al. · 2022 · Frontiers in Medicine
  34. Predictive Nomogram for Severe COVID-19 and Identification of Mortality-Related Immune Features
    Li Cai, Xi Kathy Zhou, Miao Wang, Heng Mei, Lisha Ai, Shidai Mu, Xiaoyan Zhao, Wei Chen, Yu Hu, Huafang Wang · 2020 · The Journal of Allergy and Clinical Immunology In Practice
  35. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
    Christophe Richez, René‐Marc Flipo, Françis Berenbaum, Alain G Cantagrel, Pascal Claudepierre, Françoise Debiais, Philippe Dieudé, Philippe Goupille, Christian Roux, Thierry Schaeverbeke et al. · 2020 · Joint Bone Spine
  36. Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19
    Robin Kahn, Tobias Schmidt, Karan Golestani, Anki Mossberg, Birgitta Gullstrand, Anders A Bengtsson, Fredrik Kahn · 2020 · Journal of Leukocyte Biology
  37. Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
    Raphaël M. Zellweger, T. Anh Wartel, Florian Marks, Manki Song, Jérôme H. Kim · 2020 · Expert Review of Vaccines
  38. Making a case for using γδ T cells against SARS-CoV-2
    Mahboubeh Yazdanifar, Narges Mashkour, Alice Bertaina · 2020 · Critical Reviews in Microbiology
  39. Clinical Impact Potential of Supplemental Nutrients as Adjuncts of Therapy in High-Risk COVID-19 for Obese Patients
    Emre Şahin, Cemal Orhan, Fatih Mehmet Uckun, Kazım Şahin · 2020 · Frontiers in Nutrition
  40. COVID-19: the new challenge for rheumatologists. One year later
    Ilaria Puxeddu, Francesco Ferro, Elena Bartoloni, Elena Elefante, Chiara Baldini, Carlo Alberto Scirè, Rosaria Talarico, Paola Migliorini, Marta Mosca, Stefano Bombardieri · 2021 · Clinical and Experimental Rheumatology
  41. Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis
    Fangyu Du, Wenjiao Sun, Christophe H.P. Morisseau, Bruce D. Hammock, Xuefei Bao, Qiu Liu, Chao Wang, Tan Zhang, Hao Yang, Jun Zhou et al. · 2021 · European Journal of Medicinal Chemistry
  42. Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID‐19 pneumonia
    Alperen Aksakal, Buğra Kerget, Ferhan Kerget, Seda Aşkın · 2021 · Journal of Medical Virology
  43. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses
    Kang Jin, Eric E. Bardes, Alexis Mitelpunkt, Jake Y. Wang, Surbhi Bhatnagar, Soma Sengupta, Daniel Pomeranz Krummel, Marc E. Rothenberg, Bruce J. Aronow · 2021 · iScience
  44. Therapeutic role of immunomodulators during the COVID-19 pandemic– a narrative review
    Hebah Alhajeri, Fatemah Baron, Fatemah Abutiban, Muna Al Mutairi, Yasser Ali, Adel M. Al-Awadhi, Anwar Albasri, Ali Aldei, Ahmad Alenizi, Naser Alhadhood et al. · 2022 · Postgraduate Medicine
  45. The prognostic role of micronutrient status and supplements in COVID-19 outcomes: A systematic review
    Evmorfia Pechlivanidou, Dimitriοs Vlachakis, Konstantinos Tsarouhas, Dimitris Panidis, Christina Tsitsimpikou, Christina Darviri, Demetrios Kouretas, Flora Bacopoulou · 2022 · Food and Chemical Toxicology
  46. Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
    Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, Dan Yan, Abu Bakar Siddik, Guojun Bu, Julie G. Allickson, Eva Kubrova, Arnold I. Caplan, Joshua M. Hare et al. · 2022 · Stem Cells Translational Medicine
  47. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
    Sunny Kumar, Malini Basu, Pratyasha Ghosh, Uttam Pal, Mrinal K. Ghosh · 2023 · Genes & Diseases
  48. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical)
    Mina Ghofrani Nezhad, Giti Jami, Omid Kooshkaki, Sajjad Chamani, Ali Naghizadeh · 2023 · Journal of Interferon & Cytokine Research
  49. Computational Immune Proteomics Approach to Target COVID-19
    Bruno Tilocca, Domenico Britti, Andrea Urbani, Paola Roncada · 2020 · Journal of Proteome Research
  50. Ambient Temperature Stable, Scalable COVID‐19 Polymer Particle Vaccines Induce Protective Immunity
    Shuxiong Chen, Benjamin J. Evert, Adetayo Adeniyi, Mercè Salla‐Martret, Linda H.L. Lua, Victoria Ozberk, Manisha Pandey, Michael F. Good, Andreas Suhrbier, Peter Halfmann et al. · 2021 · Advanced Healthcare Materials
  51. A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2
    Woong Kee Baek, Soo Yeon Sohn, Ahmed Mahgoub, Robert Hage · 2020 · Cureus
  52. The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic
    Rajesh Kumar, Seetha Harilal, Abdullah Godran Al-Sehemi, Githa Elizabeth Mathew, Simone Carradori, Bijo Mathew · 2020 · Current Medicinal Chemistry
  53. Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review.
    Saeid Safari, Alireza Salimi, Alireza Zali, Alireza Jahangirifard, Ehsan Bastanhagh, Reza Aminnejad, Ali Dabbagh, Amir Hossein Lotfi, Mohammad Saeidi · 2020 · Europe PMC (PubMed Central)
  54. Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
    Jeannette Wolfe, Basmah Safdar, Tracy E. Madsen, Kinjal N. Sethuraman, Bruce M. Becker, Marna Rayl Greenberg, Alyson J. McGregor · 2021 · Clinical Therapeutics
  55. Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19
    Yawen An, Bo Yuan, Jianchun Wang, Cheng Wang, Tingting Liu, Shuo Song, Hanqing Liu · 2020 · International Journal of Medical Sciences
  56. A Mid-to-Long Term Comprehensive Evaluation of Psychological Distress and Erectile Function in COVID-19 Recovered Patients
    Bintao Hu, Yajun Ruan, Kang Liu, Xian Wen Wei, Yue Wu, Huan Feng, Zhiyao Deng, Jihong Liu, Tao Wang · 2021 · The Journal of Sexual Medicine
  57. Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation
    Péter Gál, Jan Brábek, Michal Holub, Milan Jakubek, Aleksi Šedo, Lukáš Lacina, Karolína Strnadová, Petr Dubový, Helena Hornychová, Aleš Ryška et al. · 2022 · Histochemistry and Cell Biology
  58. Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome—A narrative review
    Sai Karthik, Ilango Saraswathi, Abdulaziz Alarifi, Abdulrahman Abdullah Al-Atram, Suresh Mickeymaray, Anand Paramasivam, Saleem Shaikh, Mathew Jeraud, Abdulaziz S. Alothaim · 2022 · PeerJ
  59. Hypoxia modeling techniques: A review
    Nataliya Salyha, Iryna Oliynyk · 2023 · Heliyon
  60. Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults
    Andrew Hornick, Nour Tashtish, Michael Osnard, Binita Shah, Allison Bradigan, Zainab Albar, Jeffrey Alan Tomalka, Jarrod E. Dalton, Ashish Sharma, Rafick‐Pierre Sékaly et al. · 2020 · Pathogens and Immunity
  61. COVID-19 Drug Treatment in China
    Linzi Fan, Shuang Jiang, Xin‐Rong Yang, Zhibin Wang, Chunjuan Yang · 2020 · Current Pharmacology Reports
  62. COVID-19 Infection Presenting as Acute-Onset Focal Status Epilepticus
    Jeffrey A. Swarz, Sarah Daily, Emily Niemi, Samuel G. Hilbert, Hala Ali Ibrahim, John N. Gaitanis · 2020 · Pediatric Neurology
  63. COVID-19
    Obaid Ashraf, Ahmed Virani, Tariq J. Cheema · 2020 · Critical Care Nursing Quarterly
  64. Targeting SARS‐CoV‐2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound
    Jehane Ibrahim Eid, Biswadeep B. Das, Majdah Al-Tuwaijri, Wesam Taha Basal · 2021 · Food Science & Nutrition
  65. Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective
    David G. Menter, Vahid Afshar‐Kharghan, John Paul Shen, Stephanie L. Martch, Anirban Maitra, Scott Kopetz, Kenneth V. Honn, Anil K. Sood · 2022 · Cancer and Metastasis Reviews
  66. Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders
    Md. Mominur Rahman, Sadia Afsana Mim, Mst. Afroza Alam Tumpa, Md. Taslim Sarker, Muniruddin Ahmed, Badrah Saeed Ali Alghamdi, Abdul Hafeez, Athanasios T. Alexiou, Asma Perveen, Ghulam Md Ashraf · 2022 · Cytokine
  67. Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses
    Srividhya Venkataraman · 2022 · Vaccines
  68. Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS‐CoV ‐2
    Soltan Ahmed Ebrahimi · 2020 · Drug Development Research
  69. Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?
    Daniele Giammaria, Alessandro Pajewski · 2020 · Journal of Global Health
  70. Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease 2019 Patients
    María Teresa Schiaffino, Marisa Di Natale, Elena García‐Martínez, Joaquín Navarro, José Luís Muñoz-Blanco, Pablo Demelo Rodríguez, Paloma Sánchez‐Mateos · 2020 · The Journal of Infectious Diseases
  71. Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
    Massimo Caracciolo, Sebastiano Macheda, Demetrio Labate, Marco Tescione, Stefano La Scala, Eugenio Giuseppe Vadalà, Rosalba Squillaci, Francesco D’Aleo, Antonella Morabito, Cristina Garreffa et al. · 2020 · Frontiers in Immunology
  72. A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway
    José Javier Reyes Lagos, Eric Alonso Abarca-Castro, Juan Carlos Echeverría, Hugo Mendieta Zerón, Alejandra Vargas-Caraveo, Gustavo Pacheco‐López · 2021 · Frontiers in Psychology
  73. Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study
    Nishant B. Patel, Yudhyavir Singh, Swetha Rudravaram · 2021 · Indian Journal of Critical Care Medicine
  74. In silico anti-SARS-CoV-2 activities of five-membered heterocycle-substituted benzimidazoles
    Prafullya Kumar Mudi, Rajani Kanta Mahato, Himanshu Verma, Subhra Jyoti Panda, Chandra Shekhar Purohit, Om Silakari, Bhaskar Biswas · 2022 · Journal of Molecular Structure
  75. Immune system changes in those with hypertension when infected with SARS-CoV-2
    Sheng Su, Ruirong Chen, Shaofen Zhang, Haihua Shu, Jianfang Luo · 2022 · Cellular Immunology
  76. SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosis
    Qingcong Zheng, Rongjie Lin, Yuchao Chen, Qi Lv, Jin Zhang, Jingbo Zhai, Weihong Xu, Wanming Wang · 2022 · Frontiers in Immunology
  77. Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence
    Xiyuan Bai, Tony Schountz, Ashley M. Buckle, Janet L. Talbert, Robert A. Sandhaus, Edward D. Chan · 2023 · Biochemical Society Transactions
  78. What is the actual relationship between neutrophil extracellular traps and COVID-19 severity? A longitudinal study
    Cristina de Diego-Alonso, Ana Lasierra, Lucía López-Vergara, Laura Torralba, Pablo Ruiz de Gopegui, Raquel Lahoz, Claudia Abadía, Javier Godino, Alberto Cebollada, Beatriz Jimeno et al. · 2024 · Respiratory Research
  79. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients
    Pierre-Gregoire A. Coulon, Swayam Prakash, Nisha Rajeswari Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, Robert A. Edwards, Cesar J. Figueroa, Sebastian Dominik Schubl, Lanny L. Hsieh et al. · 2024 · Frontiers in Immunology
  80. Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19
    Ziwei Hu, Wei Wang, Ying Lin, Hui Guo, Yiwen Chen, Junjie Wang, Feng Yu, Lang Rao, Zhijin Fan · 2024 · Advanced Healthcare Materials
  81. Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1
    Olga A. Tarasova, Sergey M. Ivanov, Dmitry A. Filimonov, Vladimir Poroikov · 2020 · Molecules
  82. Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
    Hye‐Kyung Lee, Ludwig Knabl, Lisa Pipperger, André Volland, Priscilla A. Furth, Keunsoo Kang, Harold E. Smith, Ludwig Knabl, Romuald Bellmann, Christina Bernhard et al. · 2021 · Scientific Reports
  83. Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication
    Wen Juan Tu, Robert McCuaig, Michelle Melino, Daniel J. Rawle, Thuy T. Le, Kexin Yan, Andreas Suhrbier, Rebecca L. Johnston, Lambros T. Koufariotis, Nicola Waddell et al. · 2021 · Cell Discovery
  84. COVID-19–Associated Acute Kidney Injury: A Case Series
    Niralee Patel, Joshua L. Rein, Luis Sanchez-Russo, Jonathan A. Winston, Jaime Uribarri · 2020 · Kidney Medicine
  85. Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
    Ahmed Mohamed Mady, Waleed Aletreby, Basheer Abdulrahman, Mohammed Haddad Lhmdi, Alfateh Sayed Nasr Noor, Saleh A. Alqahtani, Ibrahim Soliman, Abdulrahman Mishaal Alharthy, Dimitrios Karakitsos, Ziad Ahmed Memish · 2020 · Annals of Medicine and Surgery
  86. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells
    Miao Jiang, Pekka Kolehmainen, Laura Kakkola, Sari Maljanen, Krister Melén, Teemu Smura, Ilkka Julkunen, Pamela Österlund · 2021 · Microbiology Spectrum
  87. Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women
    Nardhy Gomez‐Lopez, Roberto J. Romero, Tao Li, Meyer Gershater, Yaozhu Leng, Chengrui Zou, Marcelo Farías, José Galaz, Derek Miller, Adi Laurentiu Tarca et al. · 2022 · The Journal of Immunology
  88. Deleterious effects of nervous system in the offspring following maternal SARS-CoV-2 infection during the COVID-19 pandemic
    Ruting Wang, Zifeng Wu, Chaoli Huang, Kenji Hashimoto, Ling Yang, Chun Yang · 2022 · Translational Psychiatry
  89. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
    Hendrik Luxenburger, Robert Thimme · 2023 · Gut
  90. Clinical predictors of COVID‐19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China
    Jie Liu, Zilong Liu, Weipeng Jiang, Jian Wang, Mengchan Zhu, Juan Song, Xiaoyue Wang, Ying Su, Guiling Xiang, Maosong Ye et al. · 2020 · The Clinical Respiratory Journal
  91. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations
    Giris Jacob, Anat Aharon, Benjamin Brenner · 2020 · Frontiers in Physiology
  92. Pathogenesis, Diagnosis and Possible Therapeutic Options for COVID-19
    Md. Asad Ullah, Yusha Araf, Bishajit Sarkar, Abu Tayab Moin, Riyan Al Islam Reshad, MD. Hasanur Rahman · 2020 · Journal of Clinical and Experimental Investigations
  93. SARS‐CoV‐2 innate effector associations and viral load in early nasopharyngeal infection
    Theodore G. Liou, Frederick R. Adler, Barbara C. Cahill, David Richard Cox, James Eric Cox, Garett J. Grant, Kimberly E. Hanson, Stephen C. Hartsell, Nathan D. Hatton, My N. Helms et al. · 2021 · Physiological Reports
  94. Functional consequences of SARS-CoV-2 infection in pregnant women, fetoplacental unit, and neonate
    Jorge Carvajal C, Paola C. Casanello, Alberto Toso, Marcelo Farías, Karina Carrasco‐Negüe, Kenny Araujo, Paola Valero, Javiera Fuenzalida, Caterina Solari, Luis Sobrevía · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  95. Occurrence of pulmonary embolism related to COVID-19
    Marie Hauguel‐Moreau, Mostafa El Hajjam, Quentin de Baynast, Antoine Vieillard‐Baron, Anne-Sophie Lot, Thierry Chinet, Hazrije Mustafić, Céline Bégué, Robert‐Yves Carlier, Guillaume Géri et al. · 2020 · Journal of Thrombosis and Thrombolysis
  96. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity
    Debnath Pal · 2021 · Journal of Structural Biology
  97. Emerging role of air pollution and meteorological parameters in COVID‐19
    Chan‐Na Zhao, Xinyu Fang, Ya-Ting Feng, Xue-Hui Fang, Jun He, Hai‐Feng Pan · 2021 · Journal of Evidence-Based Medicine
  98. Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2
    Shiu-Ju Yang, Ting-Chun Wei, Chih-Hao Hsu, Sin-Ni Ho, Chi-Yun Lai, Shiu‐Feng Huang, Yih-Yuan Chen, Shih‐Jen Liu, Guann‐Yi Yu, Horng-Yunn Dou · 2021 · Journal of Inflammation Research
  99. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital
    Lugyanti Sukrisman, Robert Sinto · 2021 · Journal of International Medical Research
  100. Probing the formation, structure and free energy relationships of M protein dimers of SARS-CoV-2
    Yi-Peng Cao, Rui-Rui Yang, Wei Wang, Sheng Jiang, Chengwen Yang, Ning-Bo Liu, Hong-Ji Dai, Imshik Lee, Xiang-Fei Meng, Zhiyong Yuan · 2022 · Computational and Structural Biotechnology Journal